Abstract
Objective: Lipid goal attainment in post‐acute coronary syndrome patients undergoing percutaneous coronary intervention and related factors.
Subjects and methods: A cross-sectional descriptive study on 400 patients with a recent acute coronary syndrome who had undergone percutaneous coronary intervention at Quang Tri General Hospital, followed up and re-examined at Quang Tri General Hospital, the duration of intervention was after 3 months to 24 months (had been on lipid lowering therapy for 3 months or more).
Results: the rate of reaching the target LDL-C <1,4 mmol/l in subjects after PCI was 36,8%. the rate of LDL-C reaching the target reduction >50% compared to the time of admission was 36,8%. The ratio of LDL-C decreased by >50% and reached <1,4 mmol/l was 24,8%. There was no significant effect of high potency statins on LDL-C goal attainment. Among patients who did not reach the LDL-C goal with high-intensity statins, the addition of Eztimibe helped 19,2% to achieve the goal LDL-C <1,4 mmol/l. In the group of patients with diabetes, the rate of reaching the LDL-C goal <1,4 mmol/l was higher (33.8%) than without diabetes (19.3%) with p <0,05. The rate of reaching the target Non-HDL <2,2 mmol/l and triglycerides <1,7 mmol/l were 70,3% and 60,5% respectively. Although having limitations, this study shows that the guideline-recommended LDL-C goal attainment rate is still suboptimal in a real-world setting.